Clinical Trials Logo

Recurrent Platinum-sensitive Ovarian Cancer clinical trials

View clinical trials related to Recurrent Platinum-sensitive Ovarian Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT01837251 Active, not recruiting - Clinical trials for Recurrent Platinum-sensitive Ovarian Cancer

Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Start date: May 2013
Phase: Phase 3
Study type: Interventional

Evaluation of the best therapeutic index for patients with platinum-sensitive ovarian cancer when treatment with bevacizumab and gemcitabine/carboplatin or with bevacizumab and PLD/carboplatin.